None
EN
Cancer Diagnostics Market to Reach USD 136.6 Billion by 2036 as Precision Oncology, FDA-Approved Companion Diagnostics, and AI-Driven Testing
['Fmi Analyst', '.Wp-Block-Post-Author-Name Box-Sizing Border-Box', 'Sourceurl Https', 'Www.Fmiblog.Com Wp-Includes Blocks Post-Author-Name Style.Min.Css']
FMIBlog
NEWARK, Del., Aug. 4, 2026 — The global Cancer Diagnostics Market is witnessing strong momentum as precision medicine, companion diagnostics, and advanced molecular testing continue transforming cancer detection and treatment decisions.
Anurag Sharma, Principal Analyst at Future Market InsightsWhy Is the Cancer Diagnostics Market Growing?
Which End User Leads the Cancer Diagnostics Market?
The global Cancer Diagnostics Market is projected to reach USD 136.6 billion by 2036, growing from USD 60.4 billion in 2026.
Related Reports:About Future Market Insights (FMI)Future Market Insights (FMI) is a global market intelligence and consulting firm providing comprehensive market research, competitive intelligence, and strategic business insights across industries.